Company Filing History:
4 out of 10 
2 out of 136 
1 out of 1,114 
Years Active: 2013-2018
Title: Yasutomo Nasu: Innovator in Cancer Therapeutics
Introduction
Yasutomo Nasu is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of cancer therapeutics, holding a total of 7 patents. His innovative work focuses on developing conditionally replicating adenoviruses and cancer therapeutic agents that target cancer cells effectively.
Latest Patents
One of Nasu's latest patents involves a conditionally replicating adenovirus designed to express the REIC gene. This invention aims to provide a strong anticancer effect by specifically replicating in cancer cells and expressing the REIC protein. The adenovirus is engineered by inserting full-length REIC DNA into its genome, along with additional sequences that enhance its therapeutic potential. Another notable patent is related to the direct administration of REIC/Dkk-3 to mesothelioma. This invention includes a fragment of the REIC/Dkk-3 gene that induces apoptosis in cancer cells, offering a promising avenue for cancer treatment.
Career Highlights
Throughout his career, Yasutomo Nasu has worked with various organizations, including Momotaro-gene Inc. His innovative research has positioned him as a key figure in the development of advanced cancer therapies. His work is characterized by a commitment to improving patient outcomes through scientific innovation.
Collaborations
Nasu has collaborated with notable colleagues such as Hiromi Kumon and Masami Watanabe. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yasutomo Nasu's contributions to cancer therapeutics through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new treatment options for cancer patients.